News on the Division of Blood Diseases and Resources
|
News Release
NIH study finds lung function remained stable or improved in adults after transplant So-called low-intensity blood stem cell transplants, which use milder conditioning agents than standard stem cell transplants, do not appear to damage the lungs and may help improve lung function in some patients with sickle cell disease (SCD), according to a three...
|
NHLBI in the Press
Jennelle Stephenson, 28, who was born with sickle cell disease, shared her experience of recovery after receiving genetic treatment as part of an NIH clinical trial that might hold the key to a cure of this disease.
|
NHLBI in the Press
HemoTypeSC, a low-cost and easy-to-use screening test for sickle cell disease was more than 99 percent accurate in detecting the condition in young children.
Credit:
Transfusion journal
|
Research Feature
Every two seconds someone in the United States needs blood. Five million people receive a blood transfusion every year in the U.S. In a country where blood is perennially in short supply, it is the most common medical procedure of all. Yet giving to a blood bank is not always a slam dunk—some people get turned away because of strict rules meant for...
|
Media Availability
WHAT: A scientist from the National Institutes of Health will present promising, early results from a human clinical trial testing a novel gene replacement therapy in people with severe sickle cell disease. Preliminary findings suggest that the approach has an acceptable level of safety and might help patients consistently produce normal red blood...
Credit:
Jill George, NIH
|
NHLBI in the Press
An NHLBI researcher shared encouraging results from a human clinical trial testing a novel gene replacement therapy in people with severe sickle cell disease.
|
NHLBI in the Press
A daily hydroxyurea pill has proven safe and effective for young children living with sickle cell disease in sub-Saharan Africa, where the condition is far more prevalent.